Search
Search Results
-
A Short Review of Advances in Plant-Based Antigen Production Strategies and the Production of Viral Vaccine Antigens Derived from CRISPR/Cas9 Genome Edited N. benthamiana Plants for Enhanced Vaccine Efficacy
Plant-based antigen manufacturing procedures have transformed vaccine research and industry by offering a cost-effective, scalable, and safe...
-
Plant-Based Veterinary Vaccines
Vaccines produced in plants were an alternative approach to immunization agent production. This technology allows the generation of specific pathogen...
-
Production of Plant-Based Recombinant Vaccine Against Porcine Deltacoronavirus in the Form of Bacteria-Like Particles Using Lactococcus lactis
Porcine deltacoronavirus (PDCoV) is an enteropathogenic swine coronavirus that causes severe diarrheal disease in suckling piglets and young pigs,...
-
Plant Molecular Farming for Vaccine Development
Vaccines are effective tools for the prophylaxis of infectious diseases. Various diseases have been eradicated using vaccines, and the importance of...
-
Green biotherapeutics: overcoming challenges in plant-based expression platforms
Plant-based expression platforms offer a promising avenue to produce biotherapeutics due to their scalability, cost-effectiveness, and potential for...
-
Plant-Based Antibody Manufacturing
Plant-based manufacture of antibodies and other biologics is a rapidly growing area of interest to the biopharmaceutical industry. The use of plants...
-
Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit
ObjectivesThe only approved vaccine, Bacillus Calmette Guérin (BCG) used in global tuberculosis (TB) immunization programmes has been very effective...
-
Novel edible multi-epitope vaccine construct against Enterococcus faecalis
Enterococcus faecalis is an opportunistic pathogen known to cause urinary tract and gastrointestinal infection in addition to bacteraemia,...
-
Production and immunogenicity assessment of a ToxA-based multiepitope plant-made protein targeting enteric pathogens
Around 1.7 million people die annually due to enteric infections, which are mainly caused by ETEC (Enterotoxigenic E. coli ), V. cholera , V....
-
Exploring the Potential of Plant-Based Nanotechnology in Cancer Immunotherapy: Benefits, Limitations, and Future Perspectives
AbstractReconceptualizing cancer immunotherapy can be improved if combined with plant production systems and nanotechnology. This review aims to...
-
Fish oral vaccine and mucosal immunity
Fish can be vaccinated by injection, intramuscularly (IM) or intraperitoneally (IP), and orally. Using oral immunization provides the most attractive...
-
Protective Activity of Inactivated Rabies Vaccine Using Flagellin-Based Adjuvant
AbstractRabies is a zoonotic disease with high lethality. Most human deaths are associated with the bites received from dogs and cats. Vaccination is...
-
Development, Strategies, and Challenges for Tularemia Vaccine
Francisella tularensis is a facultative intracellular bacterial pathogen that affects both humans and animals. It was developed into a biological...
-
Antibody-independent surface plasmon resonance assays for influenza vaccine quality control
AbstractSurface plasmon resonance (SPR)-based biosensors have emerged as a powerful platform for bioprocess monitoring due to their ability to detect...
-
Methods of Vaccine Delivery
Vaccination in fish is an important prophylactic measure to prevent disease outbreaks and to reduce loss due to diseases. The route of vaccination...
-
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes
AbstractDue to the high number of doses required to achieve adequate coverage in the context of COVID-19 pandemics, there is a great need for novel...
-
Using Plants as Vaccines
Vaccines are the most important strategy to fight many diseases. Plant-based vaccines have gained importance over the past decades, especially in...
-
Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2
After its emergence in late 2019 SARS-CoV-2 was declared a pandemic by the World Health Organization on 11 March 2020 and has claimed more than 2.8...
